Colombia

7 Vaccines Approved for Use in Colombia

Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
21 trials in 5 countries
Approval Source: elespectador.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: invima.gov.co
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: news.cgtn.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com

8 in Clinical Trials in Colombia

Protein Subunit

Clover

SCB-2019

15 trials in 13 countries
DNA

Inovio

INO-4800

10 trials in 9 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Inactivated

Sinovac

Trivalent COVID-19 Vaccine (Vero Cell), Inactivated

Inactivated

Valneva

VLA2001

Approved in 33 countries
9 trials in 4 countries

1 Vaccines with Trials in Colombia are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries